Export

Fisher Scientific Biotech Line A/S

Financial information

The information source is the annual report of the company with VAT No DK20940778

* Closing information (×1000) DKK

Fiscal year 202312 202212
Turnover: 0 0
Earnings before taxes: 10,232 Revenue Down 125,145 Revenue Up
Total assets: 12,389,680 Revenue Up 7,910,834 Revenue Down
Current assets: 38,361 Revenue Up 34,942 Revenue Down
Current liabilities: 76,845 Revenue Up 69,652 Revenue Down
Equity capital: 12,312,830 Revenue Up 7,841,182 Revenue Up
Share capital: 502 502
Number of employees: 15 15

Financial ratios

Solvency: 99.4% Revenue Up 99.1% Revenue Up
Turnover per employee: 0 0
Profitability: Infinity% Infinity% Revenue Up
Return on equity (ROE): 0.1% Revenue Down 1.6% Revenue Up
Current ratio: 49.9% Revenue Down 50.2% Revenue Up
Fiscal year 202312
Turnover: 0
Earnings before taxes: 10,232
Total assets: 12,389,680
Current assets: 38,361
Current liabilities: 76,845
Equity capital: 12,312,830
Share capital: 502
Number of employees: 15

Financial ratios

Solvency: 99.4%
Turnover per employee: 0
Profitability: Infinity%
Return on equity (ROE): 0.1%
Current ratio: 49.9%